newsfilter
← Latest News
PR Newswire·

Seneca Biopharma Announces the Closing of its $5 Million Registered Direct Offering

Seneca Biopharma, Inc. (Nasdaq:SNCA), a clinical-stage biopharmaceutical company developing novel treatments for various diseases of high unmet...